Results 101 to 110 of about 25,813 (258)

Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumours

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Companion canines need advances in therapeutic options for solid tumour malignancies. Natural killer (NK) cell infusions offer a promising treatment modality in canines with solid tumours. Autologous natural killer products are limited by dysfunctional immunity and a manufacturing process that delays care whereas allogeneic NK cells offer the ...
Allison M. Weisnicht   +11 more
wiley   +1 more source

Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma

open access: yesDiagnostics
Background: Multiple myeloma (MM) is a heterogeneous plasma cell malignancy with non-specific symptoms and disease heterogeneity at clinical and biological levels.
Tugba Zorlu   +5 more
doaj   +1 more source

An Annual Review of Important Apheresis Articles in 2024 From the American Society for Apheresis Attending Physician Subcommittee

open access: yes
The American Society for Apheresis (ASFA) Attending Physician Subcommittee of the Physicians' Committee performed an annual review of articles published in 2024 related to apheresis medicine. The 10 seminal apheresis articles selected by the subcommittee
Alsammak, Mohamed   +16 more
core   +1 more source

Terápiás apheresis indikáció, kezelési szám és kezelési módok a hazai terápiás gyakorlatban

open access: yes, 2020
A terápiás apheresis technikákat széleskörűen alkalmazzák sok betegség kezelésében. Munkámban összefoglalom a különböző modalitások működési elvét, az eljárás módját, továbbá taglalom az American Society for Apheresis (ASFA) ajánlásait a terápiás ...
Lobmayer, Fanni
core  

Citrate anticoagulation: Are blood donors donating bone? [PDF]

open access: yes, 2015
An estimated 2.4 million volunteer apheresis blood donation procedures were performed in the United States in 2010, and increases in the proportion of transfused blood products derived from apheresis blood collections have been consistently reported ...
Walter Bialkowski   +11 more
core   +1 more source

Manufacturing and clinical applications of non‐CAR‐T immune effector cells

open access: yes
Transfusion, EarlyView.
Thane Kubik   +2 more
wiley   +1 more source

Paris Olympics and Paralympics: Insights from nationwide coordination in preparedness, supply chain management and blood inventory

open access: yesVox Sanguinis, EarlyView.
Abstract The Paris 2024 Olympic Games posed a unique challenge due to their scale, associated risks and the need for robust healthcare preparedness. This review outlines the forecasting and anticipatory measures taken by the Etablissement français du sang (EFS) to ensure a resilient blood supply chain throughout the event.
Jean‐Baptiste Thibert   +9 more
wiley   +1 more source

Aggressive lipid-lowering therapy before and after revascularization in patients with stable coronary artery disease

open access: yesМедицинский совет, 2013
The review presents data on the effectiveness of lipid profile correction with maximum doses of statins, primarily atorvastatin, and lipoprotein apheresis.
R. N. Adzhiev   +3 more
doaj   +1 more source

Development of a Uniform Apheresis Case Report Form for Standardized Collection of Apheresis Data

open access: yes
Apheresis is performed worldwide for an increasing number of indications. The development of common data elements (CDE) for apheresis related areas may facilitate conduct of new research, enhance quality initiatives including benchmarking, and improve ...
Balogun, Rasheed A   +21 more
core   +1 more source

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

open access: yes, 2019
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease ...
Wu, Yanyun   +25 more
core   +1 more source

Home - About - Disclaimer - Privacy